Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
November 7, 2019
|
| In: |
Blood
Year: 2019, Volume: 134, Issue: 19, Pages: 1608-1618 |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood.2019001425 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: http://dx.doi.org/10.1182/blood.2019001425 |
| Author Notes: | Frank G. Rücker, Mridul Agrawal, Andrea Corbacioglu, Daniela Weber, Silke Kapp-Schwoerer, Verena I. Gaidzik, Nikolaus Jahn, Thomas Schroeder, Mohammed Wattad, Michael Lübbert, Elisabeth Koller, Thomas Kindler, Katharina Götze, Mark Ringhoffer, Jörg Westermann, Walter Fiedler, Heinz A. Horst, Richard Greil, Roland Schroers, Karin Mayer, Thomas Heinicke, Jürgen Krauter, Richard F. Schlenk, Felicitas Thol, Michael Heuser, Arnold Ganser, Lars Bullinger, Peter Paschka, Hartmut Döhner, and Konstanze Döhner, for the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG) |
| Item Description: | Gesehen am 06.05.2020 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood.2019001425 |